# AMERICAN COASTAL INSURANCE Corp (ACIC) — Financial Analysis

**Exchange:** Nasdaq  
**Coverage as of:** 2026-Q2  
**Updated:** 2026-06-03  
**Tier:** Free primer (step 2 of 19)  
**Sibling pages:** /stocks/ACIC/thesis · /stocks/ACIC/memo

## Financial Snapshot

---
source: coverage-next-full
ticker: ACIC
step: 04
title: Financial Quality & Adversarial Sweep
created: 2026-06-03
---

### Step 04 — Financial Quality & Adversarial Sweep: ACIC (American Coastal Insurance Corp)

#### Executive Summary

ACIC's financial statements present a textbook case of a complex restructuring producing clean, high-quality forward earnings. The headline financials are distorted by three legacy artifacts: (1) the $309.9M FY2023 de-consolidation gain from UPC receivership, (2) a multi-year reinsurance receivables tail from UPC claims, and (3) the -$182M equity trough in FY2022. Strip these away and the ongoing AmCoastal business shows exceptional financial quality — combined ratio 60.1%, ROE 36%, no long-term debt, conservative loss reserves. The adversarial sweep finds no active securities fraud claims or regulatory sanctions on the current ACIC entity; legacy UIHC/UPC issues are well-documented in risk factors and substantially resolved. The principal governance concern is Dan Peed's ~36% ownership + Chairman role — concentrated control with limited independent oversight.

**Overall Financial Quality Score: 7.5/10** — High for the ongoing business; scored down for legacy complexity, extreme geographic concentration, and governance structure.

---

#### 1. Financial Statement Quality Assessment

##### Complexity Assessment
ACIC's financial statements are **moderately complex** for an insurer, elevated by:

1. **Legacy UPC tail:** The balance sheet still carries ~$238M in reinsurance receivables — a residual from UPC claims being collected from reinsurers. This is a real economic asset (reinsurers owe money for Ian/other losses), but auditors must assess collectibility each quarter. The FY2025 10-K discloses this declining from a peak of ~$1.43B at the height of UPC's claims (FY2022) to $238M — demonstrating genuine cash collection, not write-offs.

2. **De-consolidation accounting:** The $309.9M FY2023 gain is a GAAP-required result of removing UPC from consolidation once it entered receivership. This is technically correct accounting, not earnings manipulation — but it requires a reader to manually strip it to see normalized economics. The 10-K discloses this clearly in the income statement as a separate line item.

3. **Reinsurance accounting:** Large ceded premiums and reinsurance recoverables create gross vs. net presentation complexity. ACIC writes policies gross and then cedes ~40-45% to reinsurers. The premium flow (gross → ceded → net) must be followed carefully; the income statement shows net premiums earned but the reinsurance program economics are material.

4. **Reserve estimation:** Loss reserves (~$450M+) require actuarial judgment. This is the primary financial statement judgment area for any insurer.

##### Reserve Adequacy Assessment
**Finding: Reserve development appears conservative (favorable).**

The historical pattern observable in ACIC's 10-K Schedule P data (loss reserve development tables required by GAAP for insurers) shows **favorable prior-year development** in recent years — meaning actual claims paid came in below what was reserved. This is the preferred outcome and indicates management is conservative, not aggressive, in reserve estimation. Specifically:
- AmCoastal's commercial residential book has shorter claim tails than personal lines (construction defect / hurricane litigation risk is lower in the commercial segment)
- The clean-year FY2023+ reserves are unburdened by UPC legacy exposure (UPC claims are separately managed by the receiver)
- No material adverse development disclosures in FY2024 or FY2025 10-K

**Caveat:** Hurricane Ian claims (2022) had unusually long tails due to Florida Assignment of Benefits (AOB) and litigation. ACIC has stated it had minimal Ian exposure (AmCoastal's commercial book had limited Ian-path overlap), but this is management representation — independently verifiable only by examining specific development triangles.

##### Reinsurance Recoverables: Collectibility
The $238M reinsurance receivable balance (FY2025) represents amounts owed by reinsurers on UPC's settled claims. Key questions:
- **Are these reinsurers solvent?** AmCoastal uses a panel of rated reinsurers (typically A-rated and above). The 10-K discloses the counterparty panel and credit ratings — material concentration in any single counterparty would be disclosed.
- **Collection track record:** The decline from $1.43B to $238M over 2-3 years demonstrates actual cash collection. These are not aging receivables; they are actively settling.
- **Residual credit risk:** $238M represents real credit exposure to reinsurance counterparties. A major reinsurer insolvency could impair this balance. The 10-K quantifies concentration risk; no single counterparty failure has been disclosed.

**Assessment:** Reinsurance receivables are real assets with manageable credit risk given the rated counterparty panel and documented collection history.

##### One-Time Items Requiring Normalization

| Item | Period | Amount | Nature | Normalize? |
|---|---|---|---|---|
| UPC de-consolidation gain | FY2023 | +$309.9M | GAAP consolidation accounting — non-cash, non-recurring | YES — exclude entirely |
| Interboro Insurance divestiture | Q2 2025 | ~$0M gain/loss (small) | Sale of NY homeowners subsidiary | Minor; exclude if material |
| Legacy UPC reinsurance settlements | FY2022-2025 | Variable | Cash inflows from reinsurer collections on old claims | Partially normalized; reflect in cash flow |
| Hard-market rate environment | FY2023-2025 | ~$30-50M above-cycle earnings | Cyclical pricing uplift | Flag in forward estimates; not excluded from historical |

##### Earnings Quality Score: **8/10** (Ongoing AmCoastal Business)
The ongoing AmCoastal business produces high-quality, contractually-backed earned premium revenue recognized ratably over policy periods. No channel stuffing, no bill-and-hold, no aggressive revenue recognition. Premium earning is governed by state insurance regulations. Investment income is mark-to-market or accrual (bonds). The principal quality risk is the loss ratio — which could spike in a catastrophic year — and reserve adequacy.

---

#### 2. Adjusted Income Statement (Normalized)

##### Normalization Methodology
Remove: (1) FY2023 de-consolidation gain ($309.9M), (2) non-recurring Interboro-related items (minor), (3) flag cyclical pricing uplift vs. long-run normalized rate environment.

##### Normalized P&L Summary

| Line Item | FY2023 Reported | FY2023 Normalized | FY2024 Reported | FY2024 Normalized | FY2025 Reported | FY2025 Normalized |
|---|---|---|---|---|---|---|
| Net Premiums Earned | ~$231M | ~$231M | ~$254M | ~$254M | ~$270M | ~$270M |
| Investment Income | ~$21M | ~$21M | ~$28M | ~$28M | ~$32M | ~$32M |
| Other Income | ~$41M | ~$41M | ~$28M | ~$28M | ~$33M | ~$33M |
| **Total Revenue** | **~$293M** | **~$293M** | **~$310M** | **~$310M** | **$335.4M** | **$335.4M** |
| Losses & LAE | ~$(86M) | ~$(86M) | ~$(91M) | ~$(91M) | ~$(100M) | ~$(100M) |
| Operating Expenses | ~$(65M) | ~$(65M) | ~$(69M) | ~$(69M) | ~$(84M) | ~$(84M) |
| **Operating Income** | ~$142M | ~$142M | ~$150M | ~$150M | ~$151M | ~$151M |
| De-consolidation Gain | +$309.9M | — | — | — | — | — |
| Other Non-recurring | ~$0 | — | — | — | — | — |
| Pre-tax Income | ~$452M | ~$142M | ~$150M | ~$150M | ~$150M | ~$150M |
| Taxes | ~$(30M) | ~$(36M) | ~$(38M) | ~$(38M) | ~$(43M) | ~$(43M) |
| **Net Income** | **$309.9M** | **~$106M** | **$75.7M** | **$75.7M** | **$106.8M** | **$106.8M** |
| **Diluted EPS** | **n/a** | **~$2.10** | **~$1.59** | **~$1.59** | **$2.15** | **$2.15** |

*FY2023 normalized removes the $309.9M gain and applies normalized tax rate. FY2024-FY2025 are already substantially clean — no normalization adjustments required beyond the FY2023 de-consolidation.*

##### Q1 2026 Snapshot (Most Recent Quarter)
- Net income: $19M
- EPS: ~$0.39
- Combined ratio: 66% (higher than FY2025 full-year 60.1% — pricing compression beginning)
- GPW: -24.5% YoY
- Interpretation: Earnings declining from peak but remaining strongly profitable; soft market is real but not catastrophic. Full-year guided pre-tax income $85-100M implies ~$65-80M net income, or ~$1.35-1.65 EPS — still a double-digit earnings yield at ~$10 stock price.

---

#### 3. Balance Sheet Quality

##### Equity Reconstruction (Key Milestone)

| Period | Shareholders' Equity | Book Value/Share | Status |
|---|---|---|---|
| FY2020 | ~$200M | ~$4.20 | Pre-Ian; UIHC consolidated |
| FY2021 | ~$100M | ~$2.10 | UPC losses mounting |
| FY2022 | ~$(182M) | ~$(3.82) | NEGATIVE — UPC crisis; Hurricane Ian |
| FY2023 | ~$200M | ~$4.21 | De-consolidation gain + AmCoastal profits rebuild |
| FY2024 | ~$260M | ~$5.48 | Continued earnings accretion |
| FY2025 | ~$318M | $6.51 | Fully rebuilt; $500M equity swing in 3 years |

The -$182M equity trough in FY2022 was a direct consequence of GAAP consolidation with UPC (which experienced catastrophic losses). Once de-consolidated, the equity "normalized" back to AmCoastal's standalone book value. The $500M swing is not organic earnings generation alone — it includes the accounting impact of removing UPC's liability-heavy balance sheet.

**Current Quality:** The FY2025 balance sheet is clean. $318M equity, no long-term debt, ~$450M+ cash and investments. The leverage ratio (debt/equity) is effectively 0%. For an insurer, the relevant leverage measure is the premium-to-surplus ratio — approximately 0.85x (net premiums written ~$270M / surplus $318M), which is conservative industry practice (1:1 is typical; up to 3:1 is common).

##### Loss Reserve Quality

Loss reserves of ~$450M+ are the largest liability on the balance sheet. Assessment:

- **Reserve-to-earned premium ratio:** ~1.65x — reasonable for commercial property with 12-18 month claim tails
- **Development history:** Favorable in recent years (claims settling below reserve) — indicates conservative initial reserving
- **Hurricane exposure:** AmCoastal's commercial residential book (condo associations primarily in coastal Florida) has direct hurricane exposure. A major Cat 4/5 direct hit on Miami or Tampa could generate losses exceeding current reserves depending on reinsurance recovery timing.
- **Actuarial sign-off:** Reserves are certified by qualified actuaries per state insurance regulations — statutory reserve adequacy reviewed by Florida OIR
- **Independent opinion:** No material reserve strengthening or restatement events disclosed in recent 10-Ks

##### Investment Portfolio
- ~$450M+ in invested assets (exact composition in 10-K Schedule D for insurance companies)
- Predominantly investment-grade fixed income (typical for Florida domiciled insurer per OIR investment guidelines)
- Equity securities represent a smaller portion
- Duration management: matched to reserve runoff to minimize interest rate mismatch
- Mark-to-market: Rising rates in 2022-2023 would have created unrealized losses; subsequent rate stabilization partially reversed these

---

#### 4. Cash Flow Analysis

##### Operating Cash Flow History

| Period | Operating CF | FCF (approx.) | Key Driver |
|---|---|---|---|
| FY2021 | ~$(295M) | ~$(295M) | UPC legacy claim payouts + reinsurance premium outflows |
| FY2022 | ~$(100M) est. | ~$(100M) | Hurricane Ian claim payments begin |
| FY2023 | ~$50M est. | ~$50M | Partial normalization; reinsurance collections begin |
| FY2024 | +$244M | +$244M | Strong year; reinsurance recoveries + AmCoastal premiums collected |
| FY2025 | +$71M | +$71M | Normalization; reinsurance settlements timing |
| TTM | +$71M | +$71M | FY2025 figure |

##### Cash Flow Quality Assessment

**FY2025 vs. FY2024 Decline Explanation:** The drop from $244M (FY2024) to $71M (FY2025) is primarily a function of reinsurance premium settlement timing, not operational deterioration:
- In FY2024, large reinsurance recoveries from prior-year claims accelerated cash inflows
- In FY2025, new reinsurance premium outflows for the renewed program and normalized recovery timing reduced net cash
- The underlying earnings power (net income $106.8M) substantially exceeds reported operating CF — explaining the difference via working capital movements

**FCF Conversion:** Insurers have minimal capex requirements (no factories, minimal PP&E). FCF ≈ Operating CF. The business generated $71M in FCF in FY2025 supporting: a $0.75/share special dividend (paid January 2026, cost ~$36M), a share repurchase program, and continued equity buildup.

**Capital Return Track Record:**
- Special dividend $0.75/share (Jan 2026): ~$36M cash returned
- No recurring dividend established — dividends declared at board discretion
- Share buybacks: Active program disclosed; repurchased shares in FY2025

**Dividend Sustainability:** At FY2025 earnings of $106.8M, the $36M special dividend represents a 34% payout ratio — very sustainable. However, FY2026 guided pre-tax income of $85-100M implies earnings compression; special dividends may be reduced or eliminated in a softer year.

---

#### 5. Key Financial Ratios (Insurer Framework)

| Metric | FY2023 | FY2024 | FY2025 | Industry Reference | Interpretation |
|---|---|---|---|---|---|
| Combined Ratio | ~66% | ~63% | 60.1% | 95-100% typical P&C | Exceptional; top-5% globally |
| Loss Ratio | ~37% | ~36% | ~37% | 60-70% typical | Below-cycle; will rise |
| Expense Ratio | ~29% | ~27% | ~23% | 25-35% typical | Lean B2B model |
| Underwriting Margin | ~34% | ~37% | ~40% | 0-5% typical | Hard-market capture |
| Net Investment Yield | ~4.5% | ~5.5% | ~6-7% est. | 3-5% typical | Benefiting from higher rates |
| ROE (normalized) | ~35%+ | ~25% | 36.2% | 10-15% typical | Above-cycle; peak earnings |
| Return on Assets | ~9% | ~7% | ~10% | 3-5% typical | Reflects low leverage |
| Premium-to-Surplus | ~1.1x | ~0.98x | ~0.85x | 1.0-3.0x typical | Conservative |
| P/B | n/m | ~1.5x | 1.52x | 1.0-2.0x typical | Reasonable for ROE level |
| P/E (normalized) | n/m | ~6.5x | ~4.9x | 8-15x typical P&C | Deeply discounted to peers |
| Dividend Yield (special) | 0% | 0% | ~7.2% (declared) | 1-3% typical | Exceptional special dividend |

**Valuation Context:** At ~4.9x trailing normalized P/E and 1.52x P/B, ACIC trades at a significant discount to standard P&C insurers. This discount reflects: (1) 100% Florida concentration risk, (2) small-cap illiquidity (~$499M market cap, $24M float), (3) near-term earnings decline from soft market, and (4) governance concerns (concentrated ownership, limited analyst coverage).

---

#### 6. Adversarial Research Sweep

*Methodology: This sweep uses SEC EDGAR filings, risk factors (10-K), public court records, regulatory filings disclosed in 10-Ks, and analyst research available through the filings/consensus path. Independent adversarial research tools (e.g., short-seller reports, litigation databases) were not used (coverage-next-full path). All findings are based on what management has disclosed or what is publicly documented in official filings.*

---

##### 6a. Legacy UIHC/UPC Issues

**UPC Receivership and Regulatory Actions**

UPC Insurance entered Florida receivership in early 2023. This was not an isolated event — it was one of the largest personal-lines insurer failures in Florida history, affecting approximately 180,000 policyholders. Key adversarial considerations:

**Florida OIR Actions:** The Florida Office of Insurance Regulation approved UPC's receivership petition. There is no public record of a separate OIR enforcement action against UIHC/ACIC management for mismanagement — the receivership was a consent process. However, OIR scrutiny of any parent company that oversees a failed insurer is standard. ACIC's 10-K risk factors acknowledge ongoing regulatory oversight.

**Securities Litigation:** ACIC/UIHC's stock declined dramatically during 2021-2022 as UPC losses mounted. This trajectory commonly attracts class-action securities fraud claims from shareholders alleging failure to disclose known material information (i.e., that UPC was insolvent). The 10-K risk factors (FY2023, FY2024) should be reviewed for disclosure of any securities class action — publicly available from EDGAR. No material unresolved securities litigation is disclosed in FY2025 10-K based on available risk factor language, though the precise wording should be independently verified by reading the full litigation disclosure in Note 12 (or equivalent contingencies note) of the FY2025 10-K.

**De-consolidation Gain Restatement Risk:** The $309.9M FY2023 gain is accounting-driven (consolidation mechanics) and was audited by a Big 4 or recognized national firm per EDGAR filing requirements. GAAP ASC 810 governs de-consolidation of subsidiaries in receivership — this is a well-established accounting standard. Restatement risk appears low, but an adversarial analyst should verify: (a) auditor identity and opinion type, (b) whether any SEC comment letter was issued regarding the de-consolidation accounting.

**Verdict on Legacy Issues:** Substantial, well-disclosed legacy risk that is actively resolving. The principal ongoing exposure is (a) reinsurance receivables collection from UPC-era reinsurers, and (b) any residual UIHC shareholder litigation not yet resolved. Neither appears material to FY2026+ operating results based on disclosed risk factors. The de-consolidation accounting appears technically correct under GAAP.

---

##### 6b. Current ACIC / AmCoastal Issues

**Insurance Regulatory Compliance**

AmCoastal is domiciled in Florida and regulated by the Florida OIR. Key regulatory risks:
- **Rate filings:** Florida OIR must approve rate changes. AmCoastal's pricing is subject to actuarial justification; there is no record of rate-filing rejection or regulatory sanction in disclosed 10-K risk factors.
- **Market conduct exams:** OIR conducts periodic market conduct examinations of Florida insurers. Any adverse exam results would be disclosed in filings — none disclosed in FY2024 or FY2025 10-Ks based on available risk factor language.
- **Claims handling complaints:** Commercial insurers face fewer consumer complaints than personal lines (sophisticated commercial policyholders, not individual homeowners). Florida's condo association market has some history of litigation-driven claims inflation, but AmCoastal's loss ratio trend (declining to 37%) suggests they are managing this effectively.

**Hurricane Ian Exposure**

AmCoastal specifically disclosed limited Hurricane Ian exposure relative to industry — the commercial residential portfolio (primarily east coast of Florida) had less direct Ian-path exposure than southwest Florida properties. No material Ian-related reserve development has been disclosed. This is a key differentiator from UPC's catastrophic Ian losses.

**Distribution Concentration: AmRisc Dependency**

AmRisc's role as sole MGA (exclusive distribution) is disclosed as a material risk in the 10-K. The relationship is governed by a Master Agency Agreement. ACIC has limited leverage if AmRisc elects to terminate or renegotiate — though this is a structural business model risk, not an adversarial "red flag." There are no disclosed disputes with AmRisc. Note: AmRisc is a related party (Dan Peed has historical ties to AmRisc's founding), raising governance questions (see 6c below).

---

##### 6c. Accounting and Governance Concerns

**Dan Peed: Concentrated Ownership and Control**

Dan Peed, Chairman of the Board, owns approximately 36% of ACIC's outstanding shares. Total insider ownership is ~49.5%. This creates several governance concerns:

1. **Shareholder rights:** Minority shareholders have limited ability to influence board composition or major corporate decisions. Standard anti-takeover provisions apply.
2. **Related-party transactions:** The AmRisc MGA relationship is a potential related-party transaction concern. If Dan Peed or affiliated entities have economic interests in AmRisc (beyond his disclosed ACIC holding), the MGA economics may not be arm's-length. ACIC's 10-K related party disclosures should be specifically reviewed to assess whether any AmRisc ownership overlaps with Dan Peed's economic interests. **This is the single most important governance risk to verify independently.**
3. **Board independence:** A board where the Chairman owns 36% of shares may have insufficient independence to challenge management on capital allocation, M&A, or executive compensation. Review proxy statement for independent director count and committee composition.
4. **Capital allocation optionality:** Peed's majority-alongside position means he effectively controls dividend policy, buyback decisions, and M&A (as a blocking minority). The special dividend (paid January 2026) benefited Peed disproportionately — receiving ~$27M on his ~36M shares — but also returned value to all shareholders proportionally.

**Reserve Estimation: Management Discretion**

Loss reserves (~$450M) require actuarial judgment. Management could theoretically under-reserve to boost current earnings. **Counter-evidence:** (1) Favorable prior-year development suggests conservative reserving, not aggressive; (2) Florida OIR requires independent actuarial certification; (3) auditors sample reserve adequacy; (4) the loss ratio of ~37% is below the historical AmCoastal average (~45-50% in pre-hard-market years), suggesting reserves are building, not depleting.

**Revenue Recognition: No Material Concerns**

Insurance premium recognition (earned over policy period) is formulaic and regulated. No judgment-based revenue recognition concerns identified. The complex item is reinsurance premium netting — which is well-disclosed and standard insurance accounting.

**Off-Balance-Sheet Risks**

The primary off-balance-sheet exposure is catastrophe reinsurance program — ACIC retains the first layer of losses before reinsurance responds. The retention amount (disclosed in the 10-K reinsurance program description) represents the maximum theoretical uninsured loss in a catastrophe year. At FY2025 combined ratio of 60.1%, ACIC could absorb a significant cat loss and still remain profitable — but a direct Cat 5 strike on Miami-Dade could potentially exhaust retention and stress the balance sheet.

---

##### 6d. Adversarial Verdict

| Risk Category | Severity | Status | Action Required |
|---|---|---|---|
| Legacy UPC shareholder litigation | MEDIUM | Likely substantially resolved; verify Note 12 in 10-K | Read contingencies footnote in FY2025 10-K |
| De-consolidation accounting | LOW | Technically correct GAAP; audited; no restatement signals | Verify auditor opinion type (clean vs. qualified) |
| OIR regulatory sanctions | LOW | None disclosed; normal oversight relationship | Monitor OIR market conduct exam results |
| AmRisc related-party risk | MEDIUM-HIGH | Material dependency; related-party economics not fully transparent | Specifically read related-party disclosures in proxy + 10-K |
| Dan Peed governance concentration | MEDIUM | Structural concern; not a fraud risk; standard for founder-controlled insurer | Accept as known risk; factor into discount rate |
| Reserve adequacy | LOW-MEDIUM | Favorable development history; conservative actuarial practice | Monitor development triangles annually |
| Hard-market earnings normalization | HIGH (not adversarial — structural) | FY2026 guide confirms earnings will decline; market aware | Normalize forward estimates for through-cycle P/E |
| Hurricane catastrophe exposure | HIGH (not adversarial — core risk) | Fundamental business risk; managed via reinsurance | Assess net retention; model cat scenario |

**Summary:** The adversarial sweep finds **no active accounting fraud, no material securities litigation, and no undisclosed regulatory sanctions** on the current ACIC entity based on publicly available filings. The most important follow-up item is reading the related-party disclosures carefully to assess whether the AmRisc MGA relationship is truly arm's-length. The legacy UPC issues are well-documented, actively resolving, and substantially de-risked from a financial statement perspective. The primary ongoing risks are structural (Florida concentration, soft market cycle) rather than adversarial (fraud, misrepresentation).

**Limitation:** This sweep is based on SEC EDGAR filings, risk factors, and consensus research — not an independent litigation database search, not court record search, not investigative journalism. A full adversarial review would additionally search PACER (federal case records), Florida state court filings, OIR enforcement orders, and short-seller research. No short-seller reports on ACIC were identified in the publicly available record reviewed here, which is itself a mild positive signal (the company is small-cap and somewhat illiquid, but structurally interesting enough to attract activist/short attention if there were visible accounting irregularities).

---

#### Source Index

| Source ID | Description |
|---|---|
| [S1] | ACIC 10-K FY2025 (SEC EDGAR CIK 0001401521) — primary financial statements, risk factors, related party disclosures, contingencies |
| [S2] | ACIC 10-K FY2024 — comparative period, reserve development tables |
| [S3] | ACIC 10-K FY2023 — de-consolidation gain disclosure, first clean AmCoastal year |
| [S4] | ACIC Q1 2026 10-Q / 8-K Earnings Release |
| [S5] | ACIC Proxy Statement (most recent) — governance, insider ownership, compensation |
| [S6] | Step 00 Data Foundation (this research package) — company identification, sector track |
| [S7] | Raymond James / Oppenheimer equity research (publicly available) — consensus estimates, normalized EPS |
| [S8] | Florida OIR public records — market conduct; no enforcement orders disclosed |
| [S9] | Insurance Information Institute — industry combined ratio benchmarks |

**Note on transcripts:** Earnings call transcripts were not used in this analysis (coverage-next-full path: filings + consensus only). Management's characterization of reserve development, AmRisc relationship quality, and forward guidance nuance from Q&A are not captured here. All forward estimates derive from filed guidance ($335-365M revenue, $85-100M pre-tax income) and analyst consensus.

## Deeper Financial Analysis

The fundamental tier ($1.00) adds 8 dimensions not included here:

- Revenue Breakdown — segment revenue, geographic mix, product-line margins
- Financial Trends — QoQ momentum, leading indicators, inflection points
- Balance Sheet — debt structure, dilution risk, working capital dynamics
- Capital Allocation — ROIC, buyback cadence, reinvestment efficiency
- Earnings Analysis — beats/misses, guidance vs actuals, transcript highlights
- Competitive Positioning — market share, pricing power, peer benchmarks
- Industry Context — TAM, sector tailwinds/headwinds, regulatory backdrop

**API endpoint:** GET /api/v1/research/ACIC/fundamental

## Navigation

- Overview: /stocks/ACIC
- Financials (this page): /stocks/ACIC/financials
- Thesis: /stocks/ACIC/thesis
- Investment Memo: /stocks/ACIC/memo
- Coverage universe: /stocks